Okamura H, Murakami T, Yokoyama C, Nakamura T, Ibata Y
Department of Anatomy and Brain Science, Kobe University School of Medicine, Japan.
J Pharmacol Exp Ther. 1997 Feb;280(2):1031-7.
Intracisternal 6-hydroxydopamine treatment to newborn rats caused massive and permanent damage of brain dopaminergic neurons, and many of these animals show self-injurious behavior (SIB) when loaded by systemic injection of L-dihydroxyphenuylalanine (L-DOPA) or D1 agonist, SKF-38393. SIB occurred at life-long time in neonatal 6-hydroxydopamine-lesioned rats, because SIB confirmed rats at 4 to 6 wk all showed SIB at 3 to 5 mo and at 12 to 13 mo after L-DOPA loading. To elucidate the brain locus important for the induction and cessation of SIB, in our study, we microinjected dopamine agonists and antagonists into various dopamine neuron innervating areas. L-DOPA-induced SIB was inhibited by the injection of a D1 antagonist, SCH-23390 (5 microg), into the bilateral substantia nigra, but not into the bilateral caudate-putamen or nucleus accumbens. The microinjection of YM-09151-2 (10 microg), a D2 antagonist, into these regions could not stop SIB. For examining the important area for the induction of SIB, we microinjected SKF-38393, D1 agonist, and/or LY-141865, D2 agonist (each 1 microg) into bilateral (or ipsilateral) caudate-putamen and substantia nigra. SIB was induced only in the case of D1 and D2 receptors in both the bilateral caudate putamen and bilateral substantia nigra being stimulated simultaneously by the mixed application of SKF-38393 and LY-141865. SIB was not induced by the sole injection of SKF-38393 into bilateral caudate-putamen or bilateral substantia nigra. These observations suggest that both caudate-putamen and nigral D1- and D2-like receptors are important for the induction of SIB, but, for cessation of SIB, up-regulated nigral D1 receptor is crucial.
给新生大鼠脑池内注射6-羟基多巴胺会导致脑多巴胺能神经元大量永久性损伤,并且许多此类动物在全身注射L-二羟基苯丙氨酸(L-DOPA)或D1激动剂SKF-38393后会出现自伤行为(SIB)。新生6-羟基多巴胺损伤的大鼠终身都会出现SIB,因为在L-DOPA注射后,4至6周龄确诊有SIB的大鼠在3至5个月以及12至13个月时均表现出SIB。为了阐明对SIB的诱导和停止至关重要的脑区,在我们的研究中,我们将多巴胺激动剂和拮抗剂微量注射到各种多巴胺神经元支配区域。向双侧黑质注射D1拮抗剂SCH-23390(5微克)可抑制L-DOPA诱导的SIB,但向双侧尾状核-壳核或伏隔核注射则不能。向这些区域微量注射D2拮抗剂YM-09151-2(10微克)无法阻止SIB。为了研究诱导SIB的重要区域,我们将D1激动剂SKF-38393和/或D2激动剂LY-141865(各1微克)微量注射到双侧(或同侧)尾状核-壳核和黑质。仅在通过SKF-38393和LY-141865联合应用同时刺激双侧尾状核-壳核和双侧黑质中的D1和D2受体时才会诱导出SIB。单独向双侧尾状核-壳核或双侧黑质注射SKF-38393不会诱导出SIB。这些观察结果表明,尾状核-壳核和黑质中的D1和D2样受体对SIB诱导均很重要,但对于SIB的停止,上调的黑质D1受体至关重要。